Mind Medicine (MindMed) Inc. (NEO: MMED.NE) AI-Powered Stock Analysis
See how Mind Medicine (MindMed) Inc. scores across key metrics like financial growth, valuation, and market position on the NEO, using AI-driven evaluation.
MMED.NE●NEO
HealthcareBiotechnology
$14.90
$1.29(9.48%)
Canadian Market opens in 14h 46m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerMind Medicine (MindMed) Inc. (NEO: MMED.NE) Stock Overall Grade
Mind Medicine (MindMed) Inc.'s grade for its NEO listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Mind Medicine (MindMed) Inc.'s overall NEO stock rating.
Forecast
C+Score
50/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Mind Medicine (MindMed) Inc. (NEO: MMED.NE) AI-Powered Stock Analysis
On the NEO, MMED.NE demonstrates Normal performance with an overall Forecast Score of 50/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NEO-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NEO: MMED.NE) Component Analysis Explained
Understand the key factors behind each Mind Medicine (MindMed) Inc. (NEO: MMED.NE) stock grade, including financials, comparisons, and forecasts.